Recent Updates
Recently added Catalysts
ARCT Positive Sentiment

Arcturus Therapeutics to Participate in Upcoming Investor Conferences

Monday, August 31, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Arcturus Therapeutics Holdings Inc. has announced its participation in two upcoming investor conferences. The company will be featured in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on September 8, 2026, and at Citi's 2026 Biopharma Back to School Conference on September 9, 2026. This engagement aims to enhance investor relations and showcase their focus on messenger RNA medicines.

Market Sentiment Analysis

POSITIVE FACTORS

  • Arcturus Therapeutics is actively engaging with investors.
  • Participation in notable conferences highlights company visibility.
  • Focus on rare disease therapeutics indicates a specialized market approach.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+73%
120-day peak, hindsight
Typical move
7.6%
average across 3 past catalysts
Cash runway
~28 mo
Minimal dilution risk
Lead asset
Metadoxine
Phase 2 · ADHD Predominantly Inattentive Type

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #65Roses--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will participate in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference (Boston) | Fireside Chat September 8, 2026 (2:15 p.m. ET) Citi's 2026 Biopharma Back to School Conference (New York) | Fireside Chat September 9

Frequently Asked Questions

What conferences will Arcturus participate in?

Arcturus will participate in the Wells Fargo Healthcare Conference and Citi's Biopharma Conference.

When is the Wells Fargo Healthcare Conference?

The Wells Fargo Healthcare Conference is scheduled for September 8, 2026.

What is the focus of Arcturus Therapeutics?

Arcturus focuses on developing messenger RNA medicines for rare liver and respiratory diseases.

What is a fireside chat?

A fireside chat is an informal discussion format often used in conferences to engage speakers and audiences.

ShareAdd on Google
Tags: ARCT Viatris Investor Conferences Healthcare Arcturus Therapeutics investor conferences biopharma messenger RNA
Last updated: Aug 31, 2026

Biotech snapshot

Cash runway
$191M liquidity · $7M/mo burn
~28 mo
Minimal dilution risk
Lead asset
MetadoxinePhase 2
ADHD Predominantly Inattentive Type →

Catalyst track record

+73%
best trade around ARCT's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for ARCT.

See every catalyst's timing & PoA →